Prospective Follow-up of the Results of Nail Arthrodesis of the Ankle
NCT ID: NCT06338566
Last Updated: 2024-03-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
20 participants
OBSERVATIONAL
2024-03-31
2026-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Patients will be asked to complete a questionnaire during follow-up consultations.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Follow-up
Follow-up at D45, 3 months and 6 months, with scoring, radiological monitoring and assessment of wound healing
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* having undergone septic nailing in the operating theatre
* with social security coverage
Exclusion Criteria
* Patient who has benefited from another means of osteosynthesis
* Patients whose long-term return to weight-bearing will not be possible for reasons other than ankle arthrodesis surgery.
* Persons able to give consent but unable to read or write French
* Opposes participation in the study
* Patients whose cognitive capacity does not allow them to answer questionnaires
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Direction Centrale du Service de Santé des Armées
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023-A01975-40
Identifier Type: OTHER
Identifier Source: secondary_id
2021PPRC10
Identifier Type: -
Identifier Source: org_study_id